CD8A and neoplasm: Specifically, CD8+ T cells function as the primary effector cells in anti-tumor immune responses, and their increased abundance can directly augment the ability to eliminate tumor cells.83 Th1 cells, conversely, indirectly potentiate anti-tumor immunity by releasing cytokines such as IFN-γ to stimulate macrophages and NK cells.